MX2021015289A - Metiltioninio como mejorador de la funcion cognitiva. - Google Patents
Metiltioninio como mejorador de la funcion cognitiva.Info
- Publication number
- MX2021015289A MX2021015289A MX2021015289A MX2021015289A MX2021015289A MX 2021015289 A MX2021015289 A MX 2021015289A MX 2021015289 A MX2021015289 A MX 2021015289A MX 2021015289 A MX2021015289 A MX 2021015289A MX 2021015289 A MX2021015289 A MX 2021015289A
- Authority
- MX
- Mexico
- Prior art keywords
- methylthioninium
- enhancers
- cognitive function
- demented
- leuco
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D25/00—Details of other kinds or types of rigid or semi-rigid containers
- B65D25/34—Coverings or external coatings
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D75/00—Packages comprising articles or materials partially or wholly enclosed in strips, sheets, blanks, tubes or webs of flexible sheet material, e.g. in folded wrappers
- B65D75/28—Articles or materials wholly enclosed in composite wrappers, i.e. wrappers formed by associating or interconnecting two or more sheets or blanks
- B65D75/30—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding
- B65D75/32—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents
- B65D75/36—Articles or materials enclosed between two opposed sheets or blanks having their margins united, e.g. by pressure-sensitive adhesive, crimping, heat-sealing, or welding one or both sheets or blanks being recessed to accommodate contents one sheet or blank being recessed and the other formed of relatively stiff flat sheet material, e.g. blister packages, the recess or recesses being preformed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61J—CONTAINERS SPECIALLY ADAPTED FOR MEDICAL OR PHARMACEUTICAL PURPOSES; DEVICES OR METHODS SPECIALLY ADAPTED FOR BRINGING PHARMACEUTICAL PRODUCTS INTO PARTICULAR PHYSICAL OR ADMINISTERING FORMS; DEVICES FOR ADMINISTERING FOOD OR MEDICINES ORALLY; BABY COMFORTERS; DEVICES FOR RECEIVING SPITTLE
- A61J1/00—Containers specially adapted for medical or pharmaceutical purposes
- A61J1/03—Containers specially adapted for medical or pharmaceutical purposes for pills or tablets
- A61J1/035—Blister-type containers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65D—CONTAINERS FOR STORAGE OR TRANSPORT OF ARTICLES OR MATERIALS, e.g. BAGS, BARRELS, BOTTLES, BOXES, CANS, CARTONS, CRATES, DRUMS, JARS, TANKS, HOPPERS, FORWARDING CONTAINERS; ACCESSORIES, CLOSURES, OR FITTINGS THEREFOR; PACKAGING ELEMENTS; PACKAGES
- B65D2203/00—Decoration means, markings, information elements, contents indicators
- B65D2203/02—Labels
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Psychiatry (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Mechanical Engineering (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Composite Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Physiology (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1909454.9A GB201909454D0 (en) | 2019-07-01 | 2019-07-01 | Enhancers |
| PCT/EP2020/068229 WO2021001306A1 (en) | 2019-07-01 | 2020-06-29 | Methylthioninium as enhancers of the cognitive function |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2021015289A true MX2021015289A (es) | 2022-01-18 |
Family
ID=67539959
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2021015289A MX2021015289A (es) | 2019-07-01 | 2020-06-29 | Metiltioninio como mejorador de la funcion cognitiva. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220330594A1 (https=) |
| EP (1) | EP3989977A1 (https=) |
| JP (1) | JP7686581B2 (https=) |
| KR (1) | KR20220028045A (https=) |
| CN (1) | CN114096254A (https=) |
| AU (1) | AU2020298737B2 (https=) |
| BR (1) | BR112021025330A2 (https=) |
| CA (1) | CA3143417A1 (https=) |
| GB (1) | GB201909454D0 (https=) |
| IL (1) | IL289341A (https=) |
| MX (1) | MX2021015289A (https=) |
| WO (1) | WO2021001306A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3121169T3 (da) | 2006-07-11 | 2022-02-28 | Wista Lab Ltd | Fremgangsmåder til syntese og/eller oprensning af diaminophenothiaziniumforbindelser |
| DK3826639T3 (da) | 2018-07-26 | 2024-09-23 | Wista Lab Ltd | Optimeret dosering af diaminophenothiaziner i populationer |
| KR102856378B1 (ko) | 2022-09-30 | 2025-09-08 | 주식회사 젬백스앤카엘 | 4r 타우병증의 치료 또는 예방용 펩티드 |
| AU2024231880A1 (en) | 2023-03-03 | 2025-09-11 | Taurx Therapeutics Management Ltd. | Diaminophenothiazine for the treatment of microvascular brain disease disease |
| KR20240176447A (ko) | 2023-06-15 | 2024-12-24 | 주식회사 젬백스앤카엘 | 신규 펩티드 및 이의 용도 |
| KR102800994B1 (ko) | 2023-11-06 | 2025-04-29 | 주식회사 엘지에너지솔루션 | 무음극 코팅층 및 이를 포함하는 전고체 전지 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0100119D0 (en) | 2001-01-03 | 2001-02-14 | Univ Aberdeen | Materials and methods relating to protein aggregation in neurodegenerative disease |
| EP2013191B3 (en) | 2006-03-29 | 2019-02-27 | Wista Laboratories Ltd. | 3,7-diamino-10h-phenothiazine salts and their use |
| CN101820884B (zh) * | 2007-06-19 | 2013-08-28 | 维斯塔实验室有限公司 | 用于治疗轻度认知缺损的吩噻嗪化合物 |
| CA3027974C (en) | 2007-10-03 | 2022-03-15 | Wista Laboratories Ltd. | Therapeutic use of diaminophenothiazines |
| EA025033B1 (ru) | 2011-02-11 | 2016-11-30 | Уиста Лэборэтэриз Лтд. | Диаминиевые соли фенотиазина и их применение |
| EP2705841A1 (en) | 2012-09-05 | 2014-03-12 | Pharnext | Combinations of nootropic agents for treating cognitive dysfunctions |
| KR102592614B1 (ko) * | 2016-07-25 | 2023-10-24 | 위스타 레보레이토리스 리미티드 | 디아미노페노티아진 (diaminophenothiazines)의 투여 및 투여량 (dosage) |
| GB201614834D0 (en) * | 2016-09-01 | 2016-10-19 | Wista Lab Ltd | Treatment of dementia |
-
2019
- 2019-07-01 GB GBGB1909454.9A patent/GB201909454D0/en not_active Ceased
-
2020
- 2020-06-29 EP EP20735367.3A patent/EP3989977A1/en active Pending
- 2020-06-29 WO PCT/EP2020/068229 patent/WO2021001306A1/en not_active Ceased
- 2020-06-29 AU AU2020298737A patent/AU2020298737B2/en active Active
- 2020-06-29 US US17/620,956 patent/US20220330594A1/en active Pending
- 2020-06-29 JP JP2021577642A patent/JP7686581B2/ja active Active
- 2020-06-29 CA CA3143417A patent/CA3143417A1/en active Pending
- 2020-06-29 CN CN202080048926.1A patent/CN114096254A/zh active Pending
- 2020-06-29 BR BR112021025330A patent/BR112021025330A2/pt unknown
- 2020-06-29 KR KR1020227003214A patent/KR20220028045A/ko not_active Ceased
- 2020-06-29 MX MX2021015289A patent/MX2021015289A/es unknown
-
2021
- 2021-12-23 IL IL289341A patent/IL289341A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GB201909454D0 (en) | 2019-08-14 |
| US20220330594A1 (en) | 2022-10-20 |
| JP2022539185A (ja) | 2022-09-07 |
| WO2021001306A1 (en) | 2021-01-07 |
| CA3143417A1 (en) | 2021-01-07 |
| KR20220028045A (ko) | 2022-03-08 |
| JP7686581B2 (ja) | 2025-06-02 |
| IL289341A (en) | 2022-02-01 |
| EP3989977A1 (en) | 2022-05-04 |
| CN114096254A (zh) | 2022-02-25 |
| AU2020298737B2 (en) | 2026-03-05 |
| BR112021025330A2 (pt) | 2022-02-01 |
| AU2020298737A1 (en) | 2022-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021015289A (es) | Metiltioninio como mejorador de la funcion cognitiva. | |
| PH12022550098A1 (en) | Parp1 inhibitors | |
| EP4360651A3 (en) | Glp-1 compositions and uses thereof | |
| ZA201805792B (en) | Taurine and aloe synergistic anti-irritant compositions and methods | |
| MX385549B (es) | Composición tipo azeótropo de hexafluoropropano, hexafluoropropeno y fluoruro de hidrógeno. | |
| MA39172B1 (fr) | Dérivés bicycliques hétérocycliques comme inhibiteurs de bromodomaines | |
| MA50817B1 (fr) | Formes et formulations solides de (s)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-n-(pyridin-2-yl)benzamide | |
| MX2020014031A (es) | Proteinas heterodimericas y usos de las mismas. | |
| TR201908247T4 (tr) | Sodyum glikoz birlikte taşıyıcı 1 inhibitörleri. | |
| NZ631601A (en) | Solid forms of a thiophosphoramidate nucleotide prodrug | |
| AU2020258568A8 (en) | CD73 inhibitors | |
| EP4361178A3 (en) | Acid-alpha glucosidase variants and uses thereof | |
| MY161390A (en) | Compositions and methods containing alkylglycosides for stabilizing protein-containing formulations | |
| MX2023004869A (es) | Anticuerpos contra sars-cov-2 y usos de los mismos. | |
| EA201591379A1 (ru) | Липопротеин-ассоциированные ингибиторы фосфолипазы a2 (lp-pla) на основе 2,3-дигидроимидазо[1,2-с]пиримидин-5(1h)-онов | |
| WO2020123816A3 (en) | Anellosomes and methods of use | |
| ZA202100672B (en) | Further substituted triazolo quinoxaline derivatives | |
| BR112018009609A2 (pt) | composições dentifrícias com absorção melhorada de fluoreto | |
| MX2022001641A (es) | Composiciones fermentadas y procedimientos de preparacion de las mismas. | |
| MX2021008022A (es) | Proteínas heterodiméricas para modular células t gamma delta. | |
| MX2021000762A (es) | Derivados de triazoloquinoxalina sustituida. | |
| MX2020006348A (es) | Pirrolidinamidas i sustituidas. | |
| BR112022008183A2 (pt) | Formas de sal de um receptor de c5a de componente do complemento | |
| UA113540C2 (xx) | Поліморфи n-(2-метоксибензоїл)-4-$(метиламінокарбоніл)аміно]бензолсульфонаміду | |
| MX2019013120A (es) | Composicion que contiene dioxido de cloro y metodos para su uso. |